Finch AI Solutions Available on the NASPO Contract
"We are so glad to be on this contract and look forward to bringing our AI solutions to state agencies looking to leverage AI to accelerate workflows, drive efficiency and make faster, more data-driven decisions," Finch AI Chief Executive Officer
Finch AI currently offers three innovative, AI-driven products. They include Finch for Text, which is an entity intelligence solution that leverages our proprietary approach to semantic understanding and a retrieval augmented generation pipeline to provide a non-negotiable base layer for getting data ready for use in AI applications; Finch Analyst, which is an AI-powered discovery and exploration surface where users can interact with their data and the inherent relationships within it from a single pane of glass; and Finch Insight Reports, which are AI-enabled entity intelligence reports that can be generated in seconds and shared instantly and easily with key stakeholders.
The NASPO ValuePoint Cooperative Purchasing Organization provides the highest standard of excellence in public cooperative contracting. By leveraging the leadership and expertise of all states with the purchasing power of their public entities, NASPO ValuePoint delivers best value, reliable, competitively sourced contracts. Since 1993 NASPO ValuePoint has been the cooperative purchasing arm of NASPO (the National Association of State Procurement Officials) encouraging, fostering and guiding the nation's most significant public contract cooperative. NASPO ValuePoint is a unified, nationally focused cooperative aggregating the demand of all 50 states, the
For more information on this vehicle, please visit: https://www.carahsoft.com/buy#naspo
To learn more about Finch AI, visit www.finchai.com.
Contact: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/finch-ai-solutions-available-on-the-naspo-contract-302490182.html
SOURCE Finch AI
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer's Disease Presented at the Alzheimer's Association International Conference�
- Ripple's $40 Billion Valuation Signals the Future of Digital Asset Infrastructure: BTCLOV.COM Draws Inspiration From Industry Leaders and Accelerates Its Next Growth Phase
- Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share